Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial-mesenchymal transition, cell migration, and invasion
- PMID: 34514618
- DOI: 10.1002/jcp.30580
Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial-mesenchymal transition, cell migration, and invasion
Abstract
Under nonpathological conditions, the extracellular nucleotide concentration remains constant and low (nM range) because of a close balance between ATP release and ATP consumption. This balance is completely altered in cancer disease. Adenine and uridine nucleotides are found in the extracellular space of tumors in high millimolar (mM) concentrations acting as extracellular signaling molecules. In general, although uridine nucleotides may be involved in different tumor cell responses, purinergic signaling in cancer is preferentially focused on adenine nucleotides and nucleosides. Extracellular ATP can bind to specific receptors (P receptors) triggering different responses, or it can be hydrolyzed by ectoenzymes bound to cell membranes to render the final product adenosine. The latter pathway plays an important role in the increase of adenosine in tumor microenvironment. In this study, we will focus on extracellular ATP and adenosine, their effects acting as ligands of specific receptors, activating ectoenzymes, and promoting epithelial-mesenchymal transition, migration, and invasion in cancer cells. Finding the roles that these nucleotides play in tumor microenvironment may be important to design new intervention strategies in cancer therapies.
Keywords: cancer; cell migration and invasion; epithelial-mesenchymal transition; extracellular ATP; extracellular adenosine; purinergic receptors.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017). The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunological Reviews, 276(1), 121-144. https://doi.org/10.1111/imr.12528
-
- Allard, D., Allard, B., & Stagg, J. (2020). On the mechanism of anti-CD39 immune checkpoint therapy. Journal for Immunotherapy of Cancer, 8(1), 1-11. https://doi.org/10.1136/jitc-2019-000186
-
- Arab, S., & Hadjati, J. (2019). Adenosine blockage in tumor microenvironment and improvement of cancer immunotherapy. Immune Network, 19(4), 1-19. https://doi.org/10.4110/in.2019.19.e23
-
- Azimi, I., Beilby, H., Davis, F. M., Marcial, D. L., Kenny, P. A., Thompson, E. W., Roberts-Thomson, S. J., & Monteith, G. R. (2016). Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells. Molecular Oncology, 10(1), 166-178. https://doi.org/10.1016/j.molonc.2015.09.006
-
- Bertoni, A. P. S., de Campos, R. P., Tsao, M., Braganhol, E., Furlanetto, T. W., & Wink, M. R. (2018). Extracellular ATP is differentially metabolized on papillary thyroid carcinoma cells surface in comparison to normal cells. Cancer Microenvironment, 11(1), 61-70. https://doi.org/10.1007/s12307-018-0206-4
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical